Sorrento Therapeutics, Inc. — Form 5500 filings & benefit plans

Form 5500 plan sponsor summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Sorrento Therapeutics, Inc. (EIN 33-0344842) is a plan sponsor located in San Diego, CA with 2 reported benefit plan(s) in the loaded dataset. The latest loaded Form 5500 filing year is 2023.

Company overview (based on loaded 2023 public filings)

EIN
33-0344842
Location
San Diego, CA
Loaded plans
2
Latest filing year
2023

Reported financial aggregate (2023)

Reported net position

Total reported assets (EOY)
$27,301,866
Total reported liabilities (EOY)
$0
Total reported net assets (EOY)
$27,301,866

Contributions & income

Employer contributions
$1,560,266
Participant contributions
$4,326,604
Total income / additions
$12,169,355

Expenses & distributions

Benefits paid / distributions
$8,514,252
Total expenses
$8,629,833
Net increase / (decrease)
$3,539,522

Coverage

Total reported participants
1,452
Plans with financial statements
1
Plans with provider compensation
1

Totals sum the latest loaded 2023 public Form 5500 filing per plan for this company's plans — one filing per plan, so multiple years are never double-counted. Figures are reported values from loaded Schedule H / I (and Schedule C for provider compensation); fields a plan did not report are treated as missing, not zero. These are not audited or official totals.

Largest loaded plans by reported assets

Sorrento Therapeutics, Inc. plans by reported end-of-year assets
PlanPlan #ParticipantsReported assets (EOY)Year
Sorrento Therapeutics, Inc. 401k Plan001826$27,301,8662023
Sorrento Therapeutics, Inc. Welfare Benefit Plan501626not reported in the loaded dataset2023

Search all 2 loaded plans for this company →

Latest loaded filings

Most recent loaded Form 5500 filings for Sorrento Therapeutics, Inc.
YearPlanParticipantsSchedulesFiling
2023Sorrento Therapeutics, Inc. Welfare Benefit Plan62620240717101518NAL0002410259001
2023Sorrento Therapeutics, Inc. 401k Plan826H, C20240827164112NAL0011179393001

Related Form 5500 pages